888-776-0942 from 8 AM - 10 PM ET
NEW YORK , Aug. 19, 2022 /PRNewswire/ -- Enteral syringes are used to deliver fluids into the gastrointestinal system of patients who are physically unable to eat or swallow. These syringes are intended for use in clinical and home care settings.
The enteral syringe market size is expected to grow by USD 355.15 mn from 2020 to 2025. In addition, the growth momentum of the market will progress at a CAGR of 5.43% during the forecast period, according to Technavio.
Get a comprehensive report summary describing the market size and forecast along with research methodology. The FREE sample report is available in PDF format
The enteral syringe market report covers the following areas:
The increasing prevalence of critical care conditions is driving the growth of the global enteral syringe market. Some of these conditions include head and neck cancer, preterm births, multiple sclerosis, motor neuron disease, head injury, stroke, and psychiatric disease. These factors, in turn, are likely to drive the adoption of enteral syringes during the forecast period.
The safety concerns related to enteral feeding are challenging the growth of the global enteral syringe market. Enteral feeding has the risk of tubing misconnection, which can lead to serious complications or death. Moreover, caregivers and nursing staff have to regularly clear syringe moats and feeding tubes and use multiple connectors and adapters for the administration of medication.
Amsino International Inc., Avanos Medical Inc., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Co., Cardinal Health Inc., GBUK Group Ltd., Medela AG, Terumo Corp., and Thermo Fisher Scientific Inc. are some of the major market participants.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
Syringe and Needle Market by End-user and Geography - Forecast and Analysis 2022-2026
Pre-filled Syringes Market by Material and Geography - Forecast and Analysis 2021-2025
Accelerate at a CAGR of 5.43%
North America, Europe, APAC, South America, and MEA
US, Germany, Canada, China, UK, and India
Leading companies, competitive strategies, consumer engagement scope
Amsino International Inc., Avanos Medical Inc., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Co., Cardinal Health Inc., GBUK Group Ltd., Medela AG, Terumo Corp., and Thermo Fisher Scientific Inc.
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Browse Health Care Market Reports
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: www.technavio.com/ Newsroom: newsroom.technavio.com/news/enteral-syringemarket
Cision Distribution 888-776-0942 from 8 AM - 9 PM ET